Literature DB >> 17623342

Sample size reestimation by Bayesian prediction.

Ming-Dauh Wang1.   

Abstract

We review a Bayesian predictive approach for interim data monitoring and propose its application to interim sample size reestimation for clinical trials. Based on interim data, this approach predicts how the sample size of a clinical trial needs to be adjusted so as to claim a success at the conclusion of the trial with an expected probability. The method is compared with predictive power and conditional power approaches using clinical trial data. Advantages of this approach over the others are discussed.

Mesh:

Year:  2007        PMID: 17623342     DOI: 10.1002/bimj.200310273

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  4 in total

1.  A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials.

Authors:  Wei Zhong; Joseph S Koopmeiners; Bradley P Carlin
Journal:  Contemp Clin Trials       Date:  2013-04-11       Impact factor: 2.226

Review 2.  The Bayesian Design of Adaptive Clinical Trials.

Authors:  Alessandra Giovagnoli
Journal:  Int J Environ Res Public Health       Date:  2021-01-10       Impact factor: 3.390

3.  The role of the Data and Safety Monitoring Board in a clinical trial: the CRISIS study.

Authors:  Richard Holubkov; T Charles Casper; J Michael Dean; K J S Anand; Jerry Zimmerman; Kathleen L Meert; Christopher J L Newth; John Berger; Rick Harrison; Douglas F Willson; Carol Nicholson
Journal:  Pediatr Crit Care Med       Date:  2013-05       Impact factor: 3.624

4.  A review and re-interpretation of a group-sequential approach to sample size re-estimation in two-stage trials.

Authors:  J Bowden; A Mander
Journal:  Pharm Stat       Date:  2014-04-02       Impact factor: 1.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.